Policy Analysis
Policy and practice rooted in evidence can save taxpayer money and lead to better health and social outcomes for all. Our associates have developed policy documents analysing pharmaceutical registration and regulatory regimes, legal gender recognition, drug policy outcomes over the past decade, myths around TRIPS flexibilities, viral hepatitis treatment access, costeffectiveness of harm reduction, gender-inclusive approaches in HIV/AIDS prevention, treatment and care, civil sector sustainability, and CSO inclusion in decision-making processes.

Report: The Brazilian COVID-19 Response
Matahari worked with the Alliance For Public Health to document the impact of COVID-19 on HIV and TB services in Bosnia and Herzegovina, Georgia, Kyrgyzstan, Moldova, Russian Federation, and Ukraine. We spoke to clinicians, communities living with HIV and TB, leaders in the COVID-19 response, and civil society experts - and found that:

  • HIV and TB detection had reduced by 25-50% in all countries during the COVID-19 pandemic;
  • There was an insufficiently broad social safety net for HIV and TB communities, threatening health outcomes;
  • There was an increase in mobile- and e-health across all countries, but that there was insufficient support to prepare communities for digital transition. 
Findings in this report were used in discussions on social support to HIV and TB communities in Moldova, and crucially were used to update government TB Mitigation Plans in Ukraine. 

All country reports are available at This Link

Media about this report:

Health Policy Watch (8 April 2021): Https://Healthpolicy-Watch.news/Hiv-And-Tb-Patients-Face-New-Barriers/
Kommersant/Коммерса́нтъ (10 April 2021): Https://Www.kommersant.ru/Doc/4769937

Report: The Brazilian COVID-19 Response
Matahari worked with the International Treatment Preparedness Coalition (ITPC) to document the Brazilian COVID-19 Response through 2020, which has been marked by high death numbers, misinformation coming from the highest levels of government, disparities in access to health services for indigenous populations, and shortages of essential health technologies. 

Read more about our findings at this link